I start this column by admitting that I just don’t know what the right policy recommendation is for state leaders concerning this pandemic. That is a change from the early days of January through ...

Financial and clinical concerns surrounding the burden of chronic kidney disease progression, as well as social determinants that factor into managing the condition in the community. Neil B. Minkoff, ...

Experts discuss the humanistic and economic impacts that affect patients with inflammatory diseases. Ryan Haumschild, PharmD, MS, MBA: When we think about these diseases, we really need to focus on ...

EXPERIENCE teaches most effectively when it comes in vivid and dramatic form. The loss of 350 lives in coal-mine accidents a year ago, in a period of three weeks, was so startling as to awaken the ...

Please provide your email address to receive an email when new articles are posted on . The prevalence of many CVD conditions and risk factors is expected to increase greatly by 2050. Health care ...

Disease X, a term used for several years by the World Health Organization, refers to a hypothetical deadly pathogen that could lead to a global pandemic. World leaders and scientists have been ...

WASHINGTON--(BUSINESS WIRE)--In a new study released today by the EveryLife Foundation for Rare Diseases, the estimated economic cost of 379 rare diseases in the United States totaled $966 billion in ...

SAN JOSE, Calif., April 14, 2014 /PRNewswire/ -- SI-BONE, Inc. (San Jose, California), a medical device company that has pioneered the use of the iFuse Implant System ®, a minimally invasive surgical ...

CNW/ - The Centre for Aging + Brain Health Innovation (CABHI), powered by Baycrest, has allocated $2.8 million CAD in funding ...

I start this column by admitting that I just don’t know what the right policy recommendation is for state leaders concerning this pandemic. That is a change from the early days of January through ...